baber/WOPTO huggingface dataset:
Patent AU-2001249852-B2 (AU)
Title: Human gene critical to fertility
Inventor: TONG ZHI-BIN
IPC: A61P15/18
Filed: 2001-04-04
Granted: 2006-10-19
Abstract: Disclosed herein are novel nucleic acid and protein sequences that are essential to fertility. In particular, human Mater cDNA and protein sequences are provided. Functional MATER is required for female fertility; zygotes that arise from Mater null oocytes do not progress beyond the two-cell stage. MATER-protein specific binding agents, such as antibodies, are described. Methods are described for detecting MATER protein in a subject, including methods for determining whether a subject has a biological condition associated with abnormal Mater expression. Also provided are kits for detecting MATER protein in a subject.
Patent AU-2001254778-B2 (AU)
Title: Biaxiallly oriented polyolefins with a reduced blocking tendency with respect to cold sealing products
Inventor: SCHISCHKO JURGEN
IPC: B32B27/32
Filed: 2001-04-05
Granted: 2006-05-11
Abstract: The invention relates to a multilayered biaxially oriented polyolefin film in the form of a release film in a laminate which is coated on an outer surface thereof with a cold seal adhesive. The release film comprises a base layer and at least one outer layer. At least one layer of the release film contains wax having an average molecular weight Mn of 200-3000. The invention also relates to a method for producing the film and the use thereof.
Patent AU-2001286334-B2 (AU)
Title: Reversible vapor compression system
Inventor: REKSTAD HAVARD
IPC: F25B9/00
Filed: 2001-08-31
Granted: 2006-08-31
Abstract: Reversible vapor compression system including a compressor ( 1 ), an interior heat exchanger ( 2 ), an expansion device ( 6 ) and an exterior heat exchanger ( 3 ) connected by means of conduits in an operable relationship to form an integral main circuit. A first device is provided in the main circuit between the compressor and the interior heat exchanger, and a second device is provided on the opposite side of the main circuit between the interior and exterior heat exchangers to enable reversing of the system from cooling mode to heating mode and vice versa. The first and second device for reversing of the system include a first and second sub-circuit (A respectively B) each of which is connected with the main circuit through a flow reversing device ( 4 and 5 respectively). Included in the system solution is a reversible heat exchanger for refrigerant fluid, particularly carbon dioxide. It includes a number of interconnected sections arranged with air flow sequentially through the sections. The first and last sections are inter-connected whereby the refrigerant fluid flow in the heat exchanger can be changed from heating to cooling mode by means of flow changing devices provided between the respective sections.
Patent AU-2002258688-B2 (AU)
Title: Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer
Inventor: FARIS MARY
IPC: C07K16/30
Filed: 2002-04-01
Granted: 2008-08-14
Abstract: A novel gene (designated 238P1B) and its encoded protein, and variants thereof, are described wherein 238P1B2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 238PL1B2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 238P1B2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 238P1B2 can be used in active or passive immunization.
Patent AU-2002311383-B2 (AU)
Title: A method of constructing a rail track in which a concrete track slab is produced and rail track anchor members are inserted into the track slab
Inventor: SKIFIC YVAN
IPC: E01B3/38
Filed: 2002-12-02
Granted: 2008-03-13
Abstract: The method involves continuously pouring concrete to form two concrete walls (2) which laterally delimit the edges of a concrete track slab to be formed. A track slab forming concrete (1) is poured between the two walls. A compact tie plate inserter system (20) is operated to insert tie plates (3) in the freshly poured track slab forming concrete.
Patent AU-2002334266-B2 (AU)
Title: Vascular occlusion solid-phase agent with immobilised platelet binding agent
Inventor: NOUJAIM ANTOINE A
IPC: A61K47/48
Filed: 2002-09-11
Granted: 2008-06-19
Abstract: The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent, causing vessel occlusion.
Patent AU-2002345943-B2 (AU)
Title: Photocrosslinking of diethyl fumarate/poly(propylene fumarate) biomaterials
Inventor: FISHER JOHN P
IPC: C08L67/06
Filed: 2002-06-28
Granted: 2007-10-18
Abstract: A polymer network formed by crosslinking poly(propylene fumarate) with a fumarate derivative. The fumarate derivative is one in which the PPF is soluble, is preferably an alkyl fumarate, and is more preferably selected from the group consisting of diethyl fumarate, dimethyl fumarate, methyl ethyl fumarate, diisopropyl fumarate, and dibutyl fumarate. The network can be formed by photo-crosslinking and can be porous. In some embodiments, the poly(propylene fumarate) and the fumarate derivative are each present in an amount effective to produce a polymeric network useful for in vivo applications. The network can be formed from an injectable, in situ crosslinkable composite formulation, or can be prefabricated from a crosslinkable composite formulation such as stereolithography, rapid prototyping, injection molding, and extrusion molding.
Patent AU-2002362541-B2 (AU)
Title: Switching device, in particular for optical applications
Inventor: BOURGEOIS CLAUDE
IPC: H02N1/00
Filed: 2002-10-04
Granted: 2007-07-05
Abstract: There is described a switching device comprising a mobile element (2) that is able to at least move back and forth along a defined trajectory between a zero position (O) and at least one predetermined switching position (A, B), an elastic member (3, 30, 32) connecting the mobile element to a base (4) and at least one stationary actuating electrode (5, 6) located in the vicinity of the predetermined switching position for producing electrostatic forces to cause the mobile element to move to and/or away from the predetermined switching position. The stationary actuating electrode is disposed to act on at least one edge (20a) of the mobile element which is substantially parallel to the mobile element's trajectory. The geometry of the mobile element, elastic member and actuating electrode is such that the mobile element cannot come into contact with the actuating electrode and that the switching position is defined by an equilibrium point (E) between lateral electrostatic forces produced on the mobile element by the stationary actuating electrode and mechanical springs forces produced by the elastic member. <IMAGE>
Patent AU-2003202551-B2 (AU)
Title: 3-Aminophenol Derivatives and Keratin Fiber Colorants Containing These Compounds
Inventor: ROSATO FRANCO JOSE
IPC: C07D333/44
Filed: 2003-01-08
Granted: 2008-02-21
Abstract: The object of the present patent application are 3-aminophenol derivatives of formula (I) or the physiologically compatible, water-soluble salts thereof and colorants based on a developer-coupler combination containing these compounds.
Patent AU-2003275051-B2 (AU)
Title: Process for reducing the level of NOx in waste gas streams using sodium chlorite
Inventor: BALMER ROBERT G
IPC: B01D53/81
Filed: 2003-05-09
Granted: 2009-10-29
Abstract: A process for reducing NOx concentrations in waste gas streams by contacting the waste gas stream with a reducing agent selected from ammonia and urea and then oxidizing the lower NOx's present in the waste gas streams to higher oxides with chlorine dioxide.
Patent AU-2003295672-B2 (AU)
Title: High flow engineering theremoplastic compositions and products made therefrom
Inventor: DEETER GARY A
IPC: C08L69/00
Filed: 2003-11-18
Granted: 2008-05-22
Abstract: High flow engineering thermoplastic compositions made from a thermoplastic host polymer and a low molecular weight flow modifier polymer, and products made therefrom. The flow modifier polymer is made by polymerizing at least one vinyl aromatic monomer and at least one (meth)acrylate monomer. The high flow engineering thermoplastics provide improved flowability and processability without sacrificing impact strength or heat resistance
Patent AU-2004231096-B2 (AU)
Title: Atomizer wicking system
Inventor: HELF THOMAS A
IPC: B05B17/06
Filed: 2004-04-14
Granted: 2009-10-08
Abstract: A replacement reservoir assembly (30) for an atomizing device (20), which uses a vibratable orifice plate (37) for atomizing liquid, includes a container (31), which contains a liquid to be atomized, and an elongated wick (56) having a lower end which is immersed in the liquid within the container (31) and an upper end located above the container (31). The wick (56) includes a dimensionally stable material having capillary passages for drawing liquid out of the container (31) to the upper end of the wick (56), which is outside the container (31). The upper end of the wick (56) has at least one surface that is configures to provide an unobstructed passage to the atmosphere from a region between a top surface of the wick (56) and a facing surface of the vibratable orifice plate (37) when the replacement reservoir is positioned in the atomizing device (30). A wick (56) for use in a replaceable reservoir assembly (30) that contains liquid to be atomized by a vibratory orifice plate (37) and a method of positioning an upper end of a solid, dimensionally stable wick (56) are also disclosed.
Patent AU-2004231243-B2 (AU)
Title: Method of increasing the gas transmission rate of a film
Inventor: HAVENS MARVIN R
IPC: B65D65/40
Filed: 2004-11-22
Granted: 2010-09-09
Abstract: A method of increasing the gas transmission rate of a packaging film comprises providing a packaging film that comprises at least about 0.001 weight % of single-walled carbon nanotube material based on the weight of the film. The packaging film is exposed to an amount of radiation energy effective to increase the oxygen transmission rate of the packaging film by at least about 100 cc (STP)/m2. day (1 atm, 0% RH, 23 DEG C). <IMAGE>
Patent AU-2004261522-B2 (AU)
Title: Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food
Inventor: NISHIMURA SHINGO
IPC: C07K5/06
Filed: 2004-07-30
Granted: 2010-09-16
Abstract: The present invention relates to a casein hydrolysate containing free amino acids and  in vivo  indigestible peptides having minimally suppressed in  vivo  enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as  in vivo  indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.
Patent AU-2004275664-B2 (AU)
Title: Height-adjustable work chair
Inventor: AMERONGEN GASTON LIONEL VAN
IPC: A47C1/0355
Filed: 2004-09-02
Granted: 2010-02-18
Abstract: Work chair, comprising a seat, supported in a height-adjustable manner by a column on a foot, and an adjustable backrest, the seat, at least in part, having a substantially horizontal position, and the backrest promoting an upright position of the user's back, characterized in that the column ( 3 ) is composed of three parts ( 4, 5, 6 ) and as a result provides a two-stage adjustability for the seat height, in that the seat is divided into two parts ( 7, 8 ), in such a manner that a rear section ( 7 ) is fixed and always retains the substantially horizontal position, while a front section ( 8 ) is hinged with respect to the rear section, and in that the front section ( 8 ) is secured to the column ( 3 ) in a hinged manner ( 11 ) by a rod ( 9 ) secured to it in a hinged manner ( 10 ). The chair can be dimensioned in such a way that it allows an ergonomic working position to be adopted by virtually all users, irrespective of their corporal size, with the possibility of increasing the size of the workstation.
Patent AU-2005200169-B2 (AU)
Title: Pet sheet
Inventor: KANEKO SHINYA
IPC: A61F13/53
Filed: 2005-01-14
Granted: 2010-11-11
Abstract: Disclosed is a pet sheet (21) including a backsheet (31), a liquid-permeable topsheet (33) and a liquid absorbent layer (25) which is smaller than the backsheet (31) and disposed between the backsheet (31) and the topsheet (33). The backsheet (31) extends beyond the liquid absorbent layer (25) to provide side regions (23,24) outside the liquid absorbent layer (25). A hydrophilic sheet (32) is provided above the backsheet (31) in the side regions (23,24). <IMAGE>
Patent AU-2005200489-B2 (AU)
Title: External support for restoring competence to venous valves by traction of their intercommissural walls
Inventor: CAMILLI SANTE
IPC: A61F2/06
Filed: 2005-02-04
Granted: 2012-07-05
Abstract: External support for restoring valvular competence to veins, to be implanted about a vein (V), along its length. It includes a posterior and an anterior arcuate frame shell, in 5 an elongated material. The posterior frame shell (1) includes two branches (2, 3) of said elongated material .penetratingly shaped for an easy insertion thereof behind the posterior wall of the vein (V), through two paths prepared by the surgeon. Each frame shell (1, 2) includes a respective traction side including longitudinal rectilinear side traction branch means (5, 5'; 5A, 5'A). The two frame shells (1, 2) are conformed to be 10 juxtaposed to each other about the vein (V) by longitudinal sides thereof. The traction sides are intended to be engaged to the vein (V) by opposite valve intercommissural walls (iw1, iw2) by means of surgical sutures (s1, s2) or hook means to dilate the intercommissural diameter of the vein by traction, so as to absorb the slackening of an incompetent venous valve by extending its cusps (c1, c2). 2AP 2A? 2' 2' 3cl 3AJ Fig. 1 Fig. 1A Fig. 2 F3 sli 2s2 Fig. 3
Patent AU-2005211580-B2 (AU)
Title: Fuel for Diesel engines
Inventor: RUDOLF TERSCHEK
IPC: C10L1/14
Filed: 2005-09-16
Granted: 2011-07-14
Abstract: Abstract The invention concerns a fuel to operate Diesel engines, in particular in cars, wherein the fuel contains an antioxidant. To achieve that the discolouration of the water white Diesel fuel during longer storage and/or incident light radiation is prevented at least for longer periods, the fuel contains a para-substituted, sterically hindered phenol (I) as antioxidant, the substituent of which in the para position is different from a tertiary butyl group.
Patent AU-2005218666-B2 (AU)
Title: Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
Inventor: ALTERMANN ERIC
IPC: C07H21/02
Filed: 2005-03-08
Granted: 2012-03-22
Abstract: Carbohydrate utilization-related and multidrug transporter nucleic acids and polypeptides, and fragments and variants therof, are disclosed in the current invention. In addition, carbohydrate utilization-related and multidrug transporter fusion proteins, antigenic peptides, and anti-carbohydrate utilization-related and antimultidrug transporter antibodies are encompassed. The invention also provides vectors containing a nucleic acid of the invention and cells into which the vector has been introduced. Methods for producing the polypeptides and methods of use for the polypeptides of the invention are further disclosed.
Patent AU-2005237488-B2 (AU)
Title: Vacuum pump with shock absorption and controlled rotation for prosthetic devices
Inventor: WILLIAMS NATHAN AARON
IPC: A61F2/60
Filed: 2005-04-22
Granted: 2010-02-25
Abstract: A vacuum pump having shock absorption and controlled rotation for use in an artificial limb. The pump includes a housing having a first chamber, and a shaft configured to be received by and to reciprocate within the first chamber, the housing and shaft forming a pump chamber. A piston may be coupled to the shaft and positioned within the pump chamber, and intake and exhaust ports are fluidly coupled to the pump chamber. Rotational structure is mounted with respect to the pump to provide controlled rotation of the shaft relative to the housing, and shock absorption structure is included within the pump to provide shock absorption for the shaft. Both a pneumatic spring and a mechanical spring element may be provided for the shock absorption structure. An optional adapter couples the shaft to the pylon of an integral pylon prosthetic foot.
Patent AU-2005244675-B2 (AU)
Title: Mucinous glycoprotein (MUC-1) vaccine
Inventor: LONGENECKER B MICHAEL
IPC: A61P35/00
Filed: 2005-04-01
Granted: 2011-07-21
Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.
Patent AU-2005295467-B2 (AU)
Title: Compositions and methods for prolonging survival of platelets
Inventor: STOSSEL THOMAS P
IPC: A61K35/19
Filed: 2005-10-17
Granted: 2011-07-07
Abstract: The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.
Patent AU-2005299537-B2 (AU)
Title: Immunoassays for lamotrigine
Inventor: ROBERTS MARK
IPC: C07K16/00
Filed: 2005-10-21
Granted: 2012-01-19
Abstract: Generally, the present invention relates to lamotrigine analogs that have substituents at the triazine 3-position and on the benzene 4-position and 5-position. The lamotrigine analogs can include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties that can be used in immunodiagnostic assays for lamotrigine. Also, the lamotrigine analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the lamotrigine analogs can be used in immunodiagnostic assays to compete with lamotrigine for binding with anti-lamotrigine antibodies.
Patent AU-2006204705-B2 (AU)
Title: ELISA assays using prion-specific peptide reagents
Inventor: MAN GAO
IPC: C07K14/47
Filed: 2006-01-13
Granted: 2011-12-01
Abstract: Peptide reagents that interact preferentially with the PrPsc form of the prion protein are described for use in detecting PrPsc in biological samples. In particular, ELISA assays are described.
Patent AU-2006213922-B2 (AU)
Title: Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
Inventor: JOHN TOFT ALEXIS
IPC: A61P13/00
Filed: 2006-02-09
Granted: 2011-09-29
Abstract: A substance for use as a medicament, comprises a solid mixed metal compound of formula (I): M .zHO (I) where M is at least one bivalent metal: M bis at least one trivalent metal; A is at least one n-valent anion; 2+a = 2b+Σcn; and Σcn < 0.9a. The substance may be made by heating at a temperature of from 200°C to 600°C, preferably from 250°C to 500°C of a substance comprising a compound of formula (II): M (OH)A .mHO (II) where M is at least one bivalent metal; M is at least one trivalent metal; Ais at least one n-valent anion; x = Σyn 0 < x ≤ 0.5, 0 < y≤ 1 and 0 <m ≤ 10.
Patent AU-2006218711-B2 (AU)
Title: Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
Inventor: NJAR VINCENT
IPC: A61K31/58
Filed: 2006-03-02
Granted: 2010-11-11
Abstract: Described are steroidal C-17 benzoazoles, pyrimidinoazoles (azabenzoazoles) and diazines. Methods for their synthesis are also described, which include methods having a step of nucleophilic vinylic "addition-elimination" substitution reaction of 3²-acetoxy-17-chloro-16-formylandrosta-5,16-diene or analogs thereof and benzoazole or pyrimidinoazole nucleophiles and methods having a palladium catalyzed cross-coupling reaction of 17-iodoandrosta-5,16-dien-3²-ol or analogs thereof with tributylstannyl diazines. The compounds are potent inhibitors of human CYP 17 enzyme as well as potent antagonists of both wild type and mutant androgen receptors (AR). The compounds are useful for the treatment of human prostate cancer.
Patent AU-2006236044-B2 (AU)
Title: A cheese flavor composition and process for making same
Inventor: KOKA RAMARATHNA
IPC: A23L27/20
Filed: 2006-11-16
Granted: 2012-05-31
Abstract: The present invention provides a cheese flavor composition and a process for preparing a cheese flavor composition comprising the steps of (a) contacting a protein containing dairy product with a lactic acid culture to form 5 a reaction mixture at a temperature of about 25 to about 45*C for about 8 to about 72 hours to provide peptides and free amino acids and, (b) contacting the peptides and free amino acids within the reaction mixture with amino acid oxidase to deaminated the peptides and free amino acids to provide a -keto acids, wherein the a -keto acids are further metabolized within the reaction 10 mixture to provide flavor compounds. The present invention also provides a food product comprising the cheese flavor composition.
Patent AU-2006246484-B2 (AU)
Title: Standby and concurring system of a power amplifier
Inventor: YUAN WENXIN
IPC: H03F3/00
Filed: 2006-11-30
Granted: 2008-07-31
Abstract: A power amplifier system including: M main power amplifiers and one standby power amplifier, where M is a positive integer; an input switching module, connected to the inputs of the M main power amplifiers and the standby power amplifier; an output switching module, connected to the outputs of the M main power amplifiers and the standby power amplifier. In the system, M groups of signals are inputted to the input switching module, processed by the power amplifiers, and then outputted from the output switching module. The standby power amplifier is independent and is capable of taking place of the faulted main power amplifier immediately without a shut down. In the system there is no correlation between the isolation of various signals and the consistency of the power amplifier, which leads to a substantial decrease of the requirement on consistency of the power amplifiers.
Patent AU-2006275424-B2 (AU)
Title: Method of preserving the function of insulin-producing cells
Inventor: CHEATHAM WAYMAN WENDELL
IPC: A61K38/28
Filed: 2006-08-01
Granted: 2013-01-10
Abstract: Methods and compositions for preserving the function of insulin-producing cells and to furthering the lifespan of insulin-producing cells in non-insulin dependent patients with insulin-related disorders are provided.